Cost- Effectiveness Study of Brief Interventions for Mood and Anxiety Disorders

Leiden University Medical Center182 enrolled

Overview

This study compares both clinical effectiveness and cost-effectiveness of a brief, intensified therapy and diagnostic method for patients with mood and/or anxiety disorders with Treatment As Usual (TAU) at five outpatient Mental Healthcare Centers in the Netherlands.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

182

Conditions

Depressive Disorder Anxiety Disorder

Interventions

Cognitive behavioral treatment/farmacotherapy interventionOTHER

Brief cognitive behavioral intervention/farmacotherapy; intake, treatment and ROM

Treatment As UsualOTHER

Other: Treatment As Usual

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Male of female adolescents * Adolescents aged between 18 to 65 year * Adolescents main complaint: Mild to moderate anxiety and/or mood disorders with or without psychiatric and/or somatic co-morbidity * Adolescents with proper understanding of the Dutch language. Exclusion Criteria: * Adolescents with current psychotic or bipolar traits, * Adolescents with homicidal or suicidal risk * Adolescents with severe social disfunctioning * No proper understanding of the Dutch language

Locations (1)

Rivierduinen

South Holland, Netherlands

Outcomes

Primary Outcomes

Effectiveness of the intervention

Effectiveness of the intervention is investigated by the main questionnaires: Web Screening Questionnaire (WSQ) and Brief Symptom Inventory (BSI) as conducted by ROM

Time frame: approximately 3 years (start: march 2010).

Secondary Outcomes

Cost-effectiveness intervention

Cost-effectiveness is explored by an open questionnaire Trimbos/iMTA Questionnaire for Cost Associated with Psychiatric Illness (TIC-P). Additionally patient and therapist satisfaction about the intervention is explored.

Time frame: approximately 3 years (start: march 2010).

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.